Based on facts I see:
1) An FDA Final Order on Reclassification, long overdue and to be announced any day, changing PEMF to Class II or Class I, leading to USA OTC
2) An FDA decision on the 510k submitted 8/6/2015, now 33 days into a 90 day process, leading to USA OTC
3) Sales increasing in triple percentage digits each quarter for 2015 over 2014, leading to profitability, licensees, and partnerships
4) Five Clinical Trials are in process for BIEL's 3 New Products to prove efficacy, helping to secure multiple licensees for this new technology
5) BIEL's research in Neuromodulation attracting licensees/partners
6) Boots is the UK's leading pharmacy-led health and beauty retailer, the ActiPatch is currently available in the online Boots Store and on the shelves of 585 of 2500 Boots Stores in the UK, poised to expand to another 1,915 Stores
7) The UK Division of B.Braun, a $6 Billion company, signed on as distributor for the RecoveryRx after Clinical Evaluation, Braun is in their corporate process of marketing a new product and running further Clinical Trials to broaden the scope of use
8) The key to success for any product are the benefits it provides to the customer. An internet search turns up hundreds of testimonials by customers describing how the ActiPatch has reduced or eliminated their pain. Read the stories of people stuck in bed due to severe pain or taking high doses of Opioid Pain Killers to make it through the day and how the ActiPatch has changed their lives for only 4 cents per hour
